We have recently utilized this assay to demonstrate that LRRK2 dependent pRab10Thr73 phosphorylation is significantly increased in PD patients carrying a heterozygous VPS35 D620N mutation that augments LRRK2 kinase activity by a yet unknown mechanism. This evidence concerns the gene LRRK2 and Parkinson disease.